|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_on1276848891 |
003 |
OCoLC |
005 |
20231120010609.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
211016s2022 enk o 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d SFB
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1276931646
|a 1277011013
|
020 |
|
|
|a 9780323911238
|q (electronic bk.)
|
020 |
|
|
|a 0323911234
|q (electronic bk.)
|
020 |
|
|
|z 9780323911221
|
020 |
|
|
|z 0323911226
|
035 |
|
|
|a (OCoLC)1276848891
|z (OCoLC)1276931646
|z (OCoLC)1277011013
|
050 |
|
4 |
|a RC112
|
082 |
0 |
4 |
|a 616.9
|2 23
|
245 |
0 |
4 |
|a The NET-heart book :
|b neglected tropical diseases and other infectious diseases affecting the heart /
|c edited by Clara Saldarriaga, Adrian Baranchuk.
|
246 |
3 |
|
|a Neglected tropical diseases and other infectious diseases affecting the heart
|
260 |
|
|
|a London :
|b Academic Press,
|c [2022]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover -- The NET-Heart Book -- The NET-Heart Book: Neglected Tropical Diseases and other Infectious Diseases affecting the Heart -- Copyright -- Contents -- Contributors -- Foreword -- Preface -- 1 -- Introduction -- Neglected tropical diseases: what are they? Epidemiology and socio-economic impact -- Relation to cardiovascular system -- Barriers to access for diagnosis and management -- The NET-Heart project -- Emerging leaders from the SIAC -- Conclusions and perspectives -- References -- 2 -- Malaria & -- Heart -- Introduction -- Epidemiology -- Physiopathology of cardiovascular (CV) involvement -- Direct cardiac effects of malaria -- CV involvement secondary to systemic effects of malaria -- Symptoms -- Diagnostic tests -- Treatment -- Discussion -- Conclusions -- References -- 3 -- Tuberculosis & -- Heart -- Introduction -- Epidemiology -- Physiopathology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 4 -- Cysticercosis & -- Heart -- Introduction -- Epidemiology -- Physiopathology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusion -- References -- 5 -- Cardiovascular Complications of Chagas' Disease -- Introduction -- Parasitology -- Epidemiology -- Pathophysiology of cardiovascular involvement -- Symptoms and clinical presentation -- Chagas' cardiomyopathy -- Myocardial dysfunction and structural abnormalities -- Conduction system alterations and rhythm disturbances -- Thromboembolic events -- Sudden cardiac death -- Diagnosis -- Diagnosis of CD -- Diagnosis of CCm -- Prognosis -- Treatment -- Treatment of Chagas' disease -- Treatment of Chagas' cardiomyopathy -- Discussion -- Conclusion -- References -- 6 -- Lyme & -- Heart -- Introduction -- Epidemiology -- Pathophysiology and cardiac involvement -- Symptoms -- Diagnostic tests.
|
505 |
8 |
|
|a Treatment -- Discussion -- Conclusion -- References -- 7 -- Leishmaniasis & -- Heart -- Introduction -- Epidemiology -- Physiopathology and cardiac involvement -- Symptoms -- Diagnostic tests -- Treatment -- Discussion -- Conclusions -- References -- 8 -- Chikungunya & -- Heart -- Introduction -- Epidemiology -- Physiopathology of cardiovascular (CV) involvement -- Symptoms -- Diagnosis -- Treatment -- Novel animal models to study CHIKV-related cardiomyopathies -- Discussion -- Conclusion -- References -- 9 -- Zika & -- Heart -- Introduction -- Epidemiology -- Pathophysiology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 10 -- COVID-19 & -- Heart -- Introduction and epidemiology -- General pathophysiology of cardiovascular involvement in COVID-19 -- Cardiovascular complications in COVID-19 patients: symptoms, diagnosis and treatment -- Acute myocardial injury -- Acute coronary syndrome -- Myocarditis -- Arrhythmias and conduction disorders -- Heart failure and cardiogenic shock -- Acute pericarditis -- Sudden death and cardiorespiratory arrest -- Venous thromboembolic disease -- Ischemic stroke -- Pediatric multisystem inflammatory syndrome (Kawasaki-like) -- Post-COVID-19 syndrome -- General treatment of COVID-19 -- Conclusions -- References -- 11 -- Trichinellosis & -- Heart -- Introduction -- Epidemiology -- Physiopathology of cardiovascular (CV) involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 12 -- HIV & -- Heart -- Introduction -- Epidemiology -- Pathophysiology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 13 -- Echinococcosis & -- Heart -- Introduction -- Epidemiology -- Physiopathology of cardiovascular (CV) involvement -- Symptoms -- Diagnosis -- Treatment.
|
505 |
8 |
|
|a Discussion -- Conclusions -- References -- 14 -- Human African Trypanosomiasis & -- Heart -- Introduction -- Epidemiology -- Physiopathology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 15 -- Snakebite & -- Heart -- Introduction -- Epidemiology -- Pathophysiology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 16 -- Rabies & -- Heart -- Introduction -- Epidemiology -- Physiopathology and clinical presentation of rabies -- Diagnosis of rabies -- Cardiac involvement in rabies -- Ante-mortem clinical evidence for cardiac involvement in rabies -- Post-mortem pathology evidence for cardiac involvement in rabies -- Treatment -- Conclusion -- References -- 17 -- Toxoplasmosis & -- Heart -- Introduction -- Epidemiology -- Epidemiology in North America -- At-risk populations -- Physiopathology -- Cardiovascular involvement -- Physiopathology in immunocompromized patients -- Symptoms -- Cardiovascular involvement -- Symptoms in immunocompromized patients -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 18 -- Schistosomiasis & -- Heart -- Introduction -- Epidemiology -- Physiopathology of cardiovascular involvement -- Signs and symptoms -- Diagnostic tests -- Treatment -- Discussion -- Conclusions -- References -- 19 -- Dengue & -- Heart -- Introduction -- Epidemiology -- Pathophysiology and cardiac involvement -- Symptoms -- Diagnosis -- Treatment -- Discussion -- Conclusions -- References -- 20 -- Neglected Tropical Diseases & -- Atrial Fibrillation -- Introduction -- Pathophysiology of NTDs leading to AF -- NTDs associated with AF -- Chagas' disease -- Zika virus disease -- Dengue fever -- Chikungunya fever -- Toxoplasmosis -- Tuberculosis -- COVID-19 -- Management of AF in patients with NTDs.
|
505 |
8 |
|
|a Treatment and elimination of NTDs -- Diagnosis of atrial fibrillation in NTDs -- Treatment of AF in NTDs -- Discussion -- Conclusion -- References -- 21 -- Electrocardiogram in Neglected Tropical Diseases -- Introduction -- NTDs and other infectious diseases -- Chagas' disease -- Lyme disease -- Human immunodeficiency virus -- Dengue -- Zika -- Chikungunya -- Tuberculosis -- Human African Trypanosomiasis -- Malaria -- Cysticercosis -- Toxoplasmosis -- Proposed approach to cardiovascular implications of neglected tropical diseases -- Conclusion -- References -- 22 -- Cardiovascular Images in Neglected Tropical Diseases -- Introduction -- Chagas' disease -- Human immunodeficiency virus (HIV) -- Tuberculosis -- Echinococcosis -- Cysticercosis -- Schistosomiasis -- Other NET-hearts diseases & -- CV images -- Gaps in evidence -- Conclusions -- Acknowledgments -- References -- Index -- Back Cover.
|
650 |
|
0 |
|a Communicable diseases
|x Complications.
|
650 |
|
0 |
|a Tropical medicine
|x Complications.
|
650 |
|
0 |
|a Heart
|x Diseases
|x Complications.
|
650 |
|
0 |
|a Comorbidity.
|
650 |
|
2 |
|a Multimorbidity
|0 (DNLM)D000076322
|
650 |
|
2 |
|a Comorbidity
|0 (DNLM)D015897
|
650 |
|
6 |
|a Maladies infectieuses
|0 (CaQQLa)201-0001354
|x Complications et s�equelles.
|0 (CaQQLa)201-0374854
|
650 |
|
6 |
|a M�edecine tropicale
|0 (CaQQLa)201-0073042
|x Complications et s�equelles.
|0 (CaQQLa)201-0374854
|
650 |
|
6 |
|a C�ur
|0 (CaQQLa)201-0005230
|x Maladies
|0 (CaQQLa)201-0005230
|x Complications et s�equelles.
|0 (CaQQLa)201-0374854
|
650 |
|
6 |
|a Comorbidit�e.
|0 (CaQQLa)201-0319011
|
650 |
|
7 |
|a Comorbidity
|2 fast
|0 (OCoLC)fst00871254
|
650 |
|
7 |
|a Heart
|x Diseases
|x Complications
|2 fast
|0 (OCoLC)fst00953530
|
700 |
1 |
|
|a Saldarriaga, Clara.
|
700 |
1 |
|
|a Baranchuk, Adrian.
|
776 |
0 |
8 |
|i Print version:
|t NET-heart book.
|d London : Academic Press, [2022]
|z 0323911226
|z 9780323911221
|w (OCoLC)1242465710
|
776 |
0 |
8 |
|i Print version:
|t NET-heart book
|z 9780323911221
|w (OCoLC)1263808512
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323911221
|z Texto completo
|